Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gary Titus currently holds 28,000 shares of SCICLONE PHARMACEUTICALS INC (SCLN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gary Titus has been a net seller of SCLN stock. They have purchased $124.4K and sold $2.1M worth of shares.
Gary Titus's most recent insider trade was on Sep 18, 2015, when they sold 10,000 shares at $0.00 per share.
Gary Titus serves as Executive at SCICLONE PHARMACEUTICALS INC (SCLN). They have executed 48 insider transactions totaling $2.2M over their tenure at the company.
Gary Titus holds the position of Executive at SCICLONE PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Gary Titus has shown a selling trading pattern, with $124.4K in total purchases and $2.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gary Titus was on Aug 25, 2006, when they sold $397.6K worth of NUVO shares. This transaction involved 20,000 shares at $19.88 per share.
Gary Titus currently owns 28,000 shares of SCICLONE PHARMACEUTICALS INC (SCLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gary Titus's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gary Titus has 48 Form 4 filings on record as an insider at SCICLONE PHARMACEUTICALS INC.
Set alerts for Gary Titus and 40,000+ other insiders.